These include decreased insulin receptor phosphorylation rendering them inactive, with subsequent development of fatty liver, increased hepatic TG content, an impaired plasma lipid profile, hyperglycemia, hyperinsulinemia, as well as impaired glucose and insulin tolerance test scores [218]. The gene discussed is INS; the disease is Hyperglycemia.